<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
    <schemaVersion>X0202</schemaVersion>
<headerData>
        <submissionType>SCHEDULE 13G/A</submissionType>
        <previousAccessionNumber>0000886982-26-000077</previousAccessionNumber>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0000886982</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <coverPageHeader>
            <amendmentNo>1</amendmentNo>
            <securitiesClassTitle>Voting Common Stock, par value $0.0001 per share</securitiesClassTitle>
            <eventDateRequiresFilingThisStatement>03/31/2026</eventDateRequiresFilingThisStatement>
            <issuerInfo>
                <issuerCik>0001788028</issuerCik>
                <issuerName>JASPER THERAPEUTICS INC</issuerName>
<issuerCusips>
                <issuerCusipNumber>471871202</issuerCusipNumber>
</issuerCusips>
                <issuerPrincipalExecutiveOfficeAddress>
                    <com:street1>2200 Bridge Pkwy Suite #102</com:street1>
                    <com:city>Redwood City</com:city>
                    <com:stateOrCountry>X1</com:stateOrCountry>
                    <com:zipCode>94065</com:zipCode>
                </issuerPrincipalExecutiveOfficeAddress>
            </issuerInfo>
            <designateRulesPursuantThisScheduleFiled>
                <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
            </designateRulesPursuantThisScheduleFiled>
        </coverPageHeader>
        <coverPageHeaderReportingPersonDetails>

            <reportingPersonName>THE GOLDMAN SACHS GROUP, INC.</reportingPersonName>
            <citizenshipOrOrganization>DE</citizenshipOrOrganization>
            <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>0.00</soleVotingPower>
                <sharedVotingPower>128862.00</sharedVotingPower>
                <soleDispositivePower>0.00</soleDispositivePower>
                <sharedDispositivePower>128862.00</sharedDispositivePower>
            </reportingPersonBeneficiallyOwnedNumberOfShares>
            <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>128862.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
            <classPercent>0.5</classPercent>
            <typeOfReportingPerson>HC</typeOfReportingPerson>
            <typeOfReportingPerson>CO</typeOfReportingPerson>
         </coverPageHeaderReportingPersonDetails>
        <coverPageHeaderReportingPersonDetails>
            <reportingPersonName>GOLDMAN SACHS &amp; CO. LLC</reportingPersonName>
            <citizenshipOrOrganization>NY</citizenshipOrOrganization>
            <reportingPersonBeneficiallyOwnedNumberOfShares>
                <soleVotingPower>0.00</soleVotingPower>
                <sharedVotingPower>128862.00</sharedVotingPower>
                <soleDispositivePower>0.00</soleDispositivePower>
                <sharedDispositivePower>128862.00</sharedDispositivePower>
            </reportingPersonBeneficiallyOwnedNumberOfShares>
            <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>128862.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
            <classPercent>0.5</classPercent>
            <typeOfReportingPerson>BD</typeOfReportingPerson>
            <typeOfReportingPerson>OO</typeOfReportingPerson>
            <typeOfReportingPerson>IA</typeOfReportingPerson>
         </coverPageHeaderReportingPersonDetails>
        <items>
            <item1>
                <issuerName>JASPER THERAPEUTICS INC</issuerName>
                <issuerPrincipalExecutiveOfficeAddress>2200 Bridge Pkwy Suite #102, Redwood City, X1,94065</issuerPrincipalExecutiveOfficeAddress>
            </item1>
            <item2>
                <filingPersonName>THE GOLDMAN SACHS GROUP, INC.| GOLDMAN SACHS &amp; CO. LLC</filingPersonName>
                <principalBusinessOfficeOrResidenceAddress>The Goldman Sachs Group, Inc. 200 West Street New York, NY 10282| Goldman Sachs &amp; Co. LLC 200 West Street New York, NY 10282</principalBusinessOfficeOrResidenceAddress>
                <citizenship>THE GOLDMAN SACHS GROUP, INC. - Delaware| GOLDMAN SACHS &amp; CO. LLC - New York</citizenship>
            </item2>
            <item3>
                <notApplicableFlag>N</notApplicableFlag>
                <typeOfPersonFiling>BD</typeOfPersonFiling>
                <typeOfPersonFiling>IA</typeOfPersonFiling>
                <typeOfPersonFiling>HC</typeOfPersonFiling>
            </item3>
            <item4>
                <amountBeneficiallyOwned>See the response(s) to Item 9 on the attached cover page(s).</amountBeneficiallyOwned>
                <classPercent>See the response(s)to Item 11 on the attached cover page(s).</classPercent>
                <numberOfSharesPersonHas>
                    <solePowerOrDirectToVote>See the response(s) to Item 5 on the attached cover page(s).</solePowerOrDirectToVote>
                    <sharedPowerOrDirectToVote>See the response(s) to Item 6 on the attached cover page(s).</sharedPowerOrDirectToVote>
                    <solePowerOrDirectToDispose>See the response(s) to Item 7 on the attached cover page(s).</solePowerOrDirectToDispose>
                    <sharedPowerOrDirectToDispose>See the response(s) to Item 8 on the attached cover page(s).</sharedPowerOrDirectToDispose>
                </numberOfSharesPersonHas>
            </item4>
            <item5>
                <notApplicableFlag>N</notApplicableFlag>
                <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
            </item5>
            <item6>
                <notApplicableFlag>Y</notApplicableFlag>
            </item6>
            <item7>
                <notApplicableFlag>N</notApplicableFlag>
                <subsidiaryIdentificationAndClassification>See Exhibit (99.2)</subsidiaryIdentificationAndClassification>
            </item7>
            <item8>
                <notApplicableFlag>Y</notApplicableFlag>
            </item8>
            <item9>
                <notApplicableFlag>Y</notApplicableFlag>
            </item9>
            <item10>
                <notApplicableFlag>N</notApplicableFlag>
                <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
            </item10>
        </items>
        <exhibitInfo>
                EXHIBIT (99.1)

                JOINT FILING AGREEMENT

                In  accordance  with Rule  13d-1(k)(1)  promulgated  under  the  Securities
                Exchange Act of 1934, the  undersigned agree to the joint filing of a Statement
                on Schedule 13G (including  any and all amendments thereto) with respect to the
                Voting Common Stock, par value $0.0001 per share, par value $ per share, of JASPER THERAPEUTICS INC
                and further agree to the filing of this agreement  as an Exhibit thereto.
                In addition, each party to this Agreement expressly authorizes each other party
                to this Agreement to file on its behalf any and all amendments to such Statement
                on Schedule 13G.

                Date:

                THE GOLDMAN SACHS GROUP, INC.

                By:/s/ Abhilasha Bareja
                ----------------------------------------
                Name:  Abhilasha Bareja
                Title:  Attorney-in-fact

                GOLDMAN SACHS &amp; CO. LLC

                By:/s/ Abhilasha Bareja
                ----------------------------------------
                Name:  Abhilasha Bareja
                Title:  Attorney-in-fact

                EXHIBIT (99.2)

                ITEM 7 INFORMATION

                The  securities   being   reported  on  by  The  Goldman  Sachs Group,  Inc.
                ("GS Group"), as  a parent  holding  company, are owned, or may be  deemed to be
                beneficially  owned, by  Goldman Sachs &amp; Co. LLC  ("Goldman  Sachs"), a broker or
                dealer  registered  under  Section  15 of  the  Act and an investment    adviser
                registered  under Section 203 of the  Investment  Advisers Act of 1940.  Goldman
                Sachs is a subsidiary of GS Group.

EXHIBIT (99.3)
ITEM 4 INFORMATION
*In accordance with the Securities and Exchange Commission Release No.
34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities
beneficially owned by certain operating units (collectively, the "Goldman Sachs
Reporting Units") of The Goldman Sachs Group, Inc. and its subsidiaries and
affiliates (collectively, "GSG"). This filing does not reflect securities, if
any, beneficially owned by any operating units of GSG whose ownership of
securities is disaggregated from that of the Goldman Sachs Reporting Units in
accordance with the Release. The Goldman Sachs Reporting Units disclaim
beneficial ownership of the securities beneficially owned by (i) any client
accounts with respect to which the Goldman Sachs Reporting Units or their
employees have voting or investment discretion or both, or with respect to
which there are limits on their voting or investment authority or both and
(ii) certain investment entities of which the Goldman Sachs Reporting Units
act as the general partner, managing general partner or other manager, to the
extent interests in such entities are held by persons other than the Goldman
Sachs Reporting Units.

        </exhibitInfo>
        <signatureInformation>
            <reportingPersonName>THE GOLDMAN SACHS GROUP, INC.</reportingPersonName>
            <signatureDetails>
                <signature>Name: Abhilasha Bareja</signature>
                <title>Attorney-in-fact</title>
                <date>04/03/2026</date>
            </signatureDetails>
        </signatureInformation>
        <signatureInformation>
            <reportingPersonName>GOLDMAN SACHS &amp; CO. LLC</reportingPersonName>
            <signatureDetails>
                <signature>Name: Abhilasha Bareja</signature>
                <title>Attorney-in-fact</title>
                <date>04/03/2026</date>
            </signatureDetails>
        </signatureInformation>
    </formData>

</edgarSubmission>
